Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

PURPOSE: In recent years, immune checkpoint inhibitors have been used in combination with tyrosine kinase inhibitors and local therapies, creating a new era in treating hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). However, the benefits of this triple therapy remain unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shu-Qun, Wu, Jun-Yi, Wu, Jia-Yi, Xie, Huang, Li, Jin-Hai, Zeng, Zhen-Xin, Fu, Yang-Kai, Liu, De-Yi, Li, Han, Chen, Wei-Zhao, Huang, Jing-Yao, Yan, Mao-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577247/
https://www.ncbi.nlm.nih.gov/pubmed/37850080
http://dx.doi.org/10.2147/JHC.S428980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577247/
https://www.ncbi.nlm.nih.gov/pubmed/37850080
http://dx.doi.org/10.2147/JHC.S428980

Ejemplares similares